127 related articles for article (PubMed ID: 3344591)
1. Extrapolation of preclinical pharmacokinetic data to therapeutic drug use.
Rahmani R; Richard B; Fabre G; Cano JP
Xenobiotica; 1988 Jan; 18 Suppl 1():71-88. PubMed ID: 3344591
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of vinca alkaloids.
Rahmani R; Zhou XJ
Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
[TBL] [Abstract][Full Text] [Related]
3. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
4. In vitro methods in human drug biotransformation research: implications for cancer chemotherapy.
Hariparsad N; Sane RS; Strom SC; Desai PB
Toxicol In Vitro; 2006 Mar; 20(2):135-53. PubMed ID: 16359840
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic and metabolic studies in the development of drugs].
Vereczkey L
Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
[TBL] [Abstract][Full Text] [Related]
6. Drug research: from the idea to the product.
Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
8. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(6):623-8. PubMed ID: 11985336
[TBL] [Abstract][Full Text] [Related]
9. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
Srinivas NR
Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
[TBL] [Abstract][Full Text] [Related]
10. Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
Evans CA; Jolivette LJ; Nagilla R; Ward KW
Drug Metab Dispos; 2006 Jul; 34(7):1255-65. PubMed ID: 16621936
[TBL] [Abstract][Full Text] [Related]
11. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
[TBL] [Abstract][Full Text] [Related]
15. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
Beaumont K; Smith DA
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
[TBL] [Abstract][Full Text] [Related]
16. Extrapolation of preclinical data into clinical reality translational science.
Singer T
Ernst Schering Res Found Workshop; 2007; (59):1-5. PubMed ID: 17117711
[TBL] [Abstract][Full Text] [Related]
17. Preclinical and clinical pharmacology of vinca alkaloids.
Zhou XJ; Rahmani R
Drugs; 1992; 44 Suppl 4():1-16; discussion 66-9. PubMed ID: 1283846
[TBL] [Abstract][Full Text] [Related]
18. Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension.
Zhou XJ; Placidi M; Rahmani R
Anticancer Res; 1994; 14(3A):1017-22. PubMed ID: 8074443
[TBL] [Abstract][Full Text] [Related]
19. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Gómez-Lechón MJ; Castell JV; Donato MT
Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Data Extrapolation to Clinical Reality: A Translational Approach.
Varshney P; Chandra P
Curr Drug Discov Technol; 2024 Apr; ():. PubMed ID: 38676496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
